Back to Research Studies
Validation of REEV SENSE biomarkers precision for gait analysis for participants with post-stroke gait impairment
PI/Study Coordinator
Amaury Ciurana, MS, CEO & Co-Founder of REEV

The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker on participants with gait impairment related to a stroke and to compare it with a reference motion capture method. REEV SENSE is intended to quantify the gait characteristics of a subject with a simple procedure adapted to clinical routine use, under the clinical supervision of a trained healthcare professional. For more information, see the study advertisement on Linkedin or the REEV website.

Participants are requested to commit up to one and a half hours for the study and may be compensated up to $50.

Testing will take place at the MIT's Center for Clinical and Translational Research (CCTR) located at 45 Carleton Street, Cambridge MA.

Please fill out this screening form if you are interested in potentially being contacted by a researcher to participate in this study!

Contact name
Amaury Ciurana, MS
Contact email
amaury.ciurana [at] reev.care
Contact phone
1-857-210-9698